Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.67 -0.09 (-3.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Eledon Pharmaceuticals (ELDN) Current Deferred Revenue (2022 - 2026)

Updated

Analysis

Eledon Pharmaceuticals (ELDN) Current Deferred Revenue (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eledon Pharmaceuticals 313.62 Mn 224.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381,000.00
Mar 31, 2026 369,000.00
Dec 31, 2025 358,000.00
Sep 30, 2025 346,000.00
Jun 30, 2025 336,000.00
Mar 31, 2025 325,000.00
Dec 31, 2024 314,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 269,000.00
Mar 31, 2024 284,000.00
Dec 31, 2023 383,000.00
Sep 30, 2023 396,000.00
Jun 30, 2023 390,000.00
Mar 31, 2023 384,000.00
Dec 31, 2022 363,000.00
API Access

Eledon Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELDN&period=max&api_key=YOUR_API_KEY